From: Understanding the public’s role in reducing low-value care: a scoping review
Characteristic | N (%) |
---|---|
Year of publication | |
1980–1999 | 3 (1.4) |
2000–2009 | 23 (10.5) |
2010–2019 | 192 (88.1) |
Continent of origin | |
North America | 146 (66.7) |
Europe | 41 (18.7) |
Australia | 20 (9.2) |
Asia | 8 (3.7) |
Africa | 1 (0.5) |
South America | 1 (0.5) |
Oceania | 1 (0.5) |
Type of article | |
Original Research | 138 (63.3) |
Observationala | 34 (15.5) |
Qualitative | 28 (12.8) |
Randomized controlled trials | 21 (9.6) |
Non-randomized experimental | 13 (5.9) |
Knowledge synthesis | 12 (5.5) |
Consensus method | 11 (5.0) |
Mixed methods | 8 (3.7) |
Community jury | 8 (3.7) |
Otherb | 3 (1.7) |
Non-original research | 80 (36.5) |
Narrative review | 34 (15.5) |
Editorial/commentary | 34 (15.5) |
Website items | 10 (4.5) |
Policy report | 2 (0.9) |
Type of low-value care | |
Low-value care in general | 95 (43.4) |
Specific low-value practice(s) | 124 (56.6) |
Test | 38 (17.4) |
Treatment | 69 (31.5) |
Both | 16 (7.3) |
Clinical setting | |
Hospital | 42 (19.2) |
Primary care | 35 (16.0) |
Emergency Department | 22 (10.0) |
Communityc | 27 (12.4) |
Not specified | 92 (42.0) |
Level of public engagementd | |
Patient interaction | 156 (71.6) |
Research | 56 (25.7) |
Policy/administration | 33 (15.1) |